Sodium chloride 0.18% Glucose 4% infusion 1litre Viaflo bags

Land: Bretland

Tungumál: enska

Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)

Virkt innihaldsefni:

Glucose anhydrous; Sodium chloride

Fáanlegur frá:

Baxter Healthcare Ltd

INN (Alþjóðlegt nafn):

Glucose anhydrous; Sodium chloride

Skammtar:

40mg/1ml ; 1.8mg/1ml

Lyfjaform:

Infusion

Stjórnsýsluleið:

Intravenous

Tegund:

No Controlled Drug Status

Gerð lyfseðils:

Valid as a prescribable product

Vörulýsing:

BNF: 09020201

Vara einkenni

OBJECT 1
SODIUM CHLORIDE 0.18% AND GLUCOSE 4 %
SOLUTION FOR INFUSION BP
Summary of Product Characteristics Updated 14-Jul-2016 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Sodium Chloride 0.18% and Glucose 4 % Solution for Infusion BP
2. Qualitative and quantitative composition
Sodium Chloride:
1.80 g/l
Glucose (as
monohydrate):
40.00 g/l
Each ml contains 1.8 mg sodium chloride and 40 mg glucose (as
monohydrate).
mmol/l (approx):
Na+: 30 Cl
-
: 30
Approximately:
668 kJ/l (or 160 kcal)
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Solution for infusion.
Clear solution, free from visible particles
4. Clinical particulars
4.1 Therapeutic indications
Sodium Chloride 0.18 % and Glucose 4% solution is used in the
following indications:
Dehydration treatment due to a moderated loss of sodium and chloride
(vomiting, diarrhoea, renal
disorders, overuse of diuretics) in cases where a source of energy is
required (particularly starvation).
Paediatric Population
This product should only be used in paediatric specialist settings
(such as renal, hepatic and cardiac units,
high dependency units and intensive care units) for intravenous fluid
therapy requiring the use of 0.18%
sodium chloride and 4% glucose to maintain fluid and electrolyte
balance.
4.2 Posology and method of administration
The choice of the specific sodium chloride and glucose concentration,
dosage, volume, rate and duration
of administration depends on the age, weight, clinical condition of
the patient and concomitant therapy. It
should be determined by a physician. For patients with electrolyte and
glucose abnormalities and for
paediatric patients, consult a physician experienced in intravenous
fluid therapy. Rapid correction of
hyponatraemia and hypernatraemia is potentially dangerous (risk of
serious neurologic complications).
_ADULTS, OLDER PATIENTS AND ADOLESCENTS (AGE 12 YEARS AND OVER):_
The Recommended dosage is 500 ml to 3 L/24h
Administration rate
The infusion rate is usually 40 ml/kg/24h and should not exceed t